"In clinical trials of Wegovy, hair loss was reported in 2.5% of Wegovy-treated adult patients versus 1.0% of placebo-treated adult patients," the company spokesperson said
the FDA prescribing information specifies weekly administration because semaglutides ~7-day half-life maintains clinically meaningful levels across the week
Feel-Full Formula for Metabolic Wellness
I even wore a fitted dress last weekend
NEJM 2023: 10.1056/NEJMoa2301972 Phase 2 dose-response (1, 4, 8, 12 mg arms, 48 wk, non-diabetic obesity)
The post's monitoring table names HbA1c, describing it as reflecting average blood glucose over roughly three months and calling it the gold standard for long-term glycemic control